CITRAVESCENT granules sachet (reformulation)

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

sodium bicarbonate, Quantity: 1.32 g; citric acid, Quantity: 1.23 g; tartaric acid, Quantity: 0.4 g; sodium carbonate, Quantity: 0.08 g

Prieinama:

Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare

INN (Tarptautinis Pavadinimas):

citric acid,sodium bicarbonate,sodium carbonate,tartaric acid

Vaisto forma:

Granules, effervescent

Sudėtis:

Excipient Ingredients: lactose monohydrate; sucrose

Vartojimo būdas:

Oral

Vienetai pakuotėje:

8 sachets, 10 sachets, 25 sachets, 28 sachets, 20 sachets

Recepto tipas:

Not scheduled. Not considered by committee

Terapinės indikacijos:

Systemic and urinary alkalinisation where indicated in the relief of symptoms associated with urinary tract infections such as cystitis, pyelonephritis, urethritis; and in reducing the formation of uric acid and cystine calculi. Citravescent may increase the effectiveness of sulphonamide antibiotics in the treatment of urinary tract infection. Acid indigestion or heartburn.

Produkto santrauka:

Visual Identification: White granules; Container Type: Sachet; Container Material: Al laminated with LDPE/paper; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Autorizacija statusas:

Licence status A

Leidimo data:

2013-08-15